PortfoliosLab logoPortfoliosLab logo
AHCO vs. XBIT
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

AHCO vs. XBIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AdaptHealth Corp. (AHCO) and XBiotech Inc. (XBIT). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

AHCO vs. XBIT - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
AHCO
AdaptHealth Corp.
19.08%4.62%30.59%-62.07%-21.42%-34.88%242.08%11.70%1.34%
XBIT
XBiotech Inc.
-2.09%-39.49%-1.25%13.96%-68.46%-17.46%-16.15%267.42%20.09%

Fundamentals

EPS

AHCO:

-$0.53

XBIT:

-$0.96

Total Revenue (TTM)

AHCO:

$2.84B

XBIT:

$0.00

Gross Profit (TTM)

AHCO:

$20.97M

XBIT:

-$427.00K

EBITDA (TTM)

AHCO:

$126.48M

XBIT:

-$27.00M

Returns By Period

In the year-to-date period, AHCO achieves a 19.08% return, which is significantly higher than XBIT's -2.09% return.


AHCO

1D
-0.34%
1M
23.03%
YTD
19.08%
6M
30.19%
1Y
9.61%
3Y*
-1.55%
5Y*
-20.39%
10Y*

XBIT

1D
-0.43%
1M
0.86%
YTD
-2.09%
6M
-11.36%
1Y
-22.52%
3Y*
-12.14%
5Y*
-30.80%
10Y*
-11.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AHCO vs. XBIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AHCO
AHCO Risk / Return Rank: 4747
Overall Rank
AHCO Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
AHCO Sortino Ratio Rank: 4646
Sortino Ratio Rank
AHCO Omega Ratio Rank: 4444
Omega Ratio Rank
AHCO Calmar Ratio Rank: 4848
Calmar Ratio Rank
AHCO Martin Ratio Rank: 4848
Martin Ratio Rank

XBIT
XBIT Risk / Return Rank: 2121
Overall Rank
XBIT Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
XBIT Sortino Ratio Rank: 2424
Sortino Ratio Rank
XBIT Omega Ratio Rank: 2424
Omega Ratio Rank
XBIT Calmar Ratio Rank: 1616
Calmar Ratio Rank
XBIT Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AHCO vs. XBIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AdaptHealth Corp. (AHCO) and XBiotech Inc. (XBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AHCOXBITDifference

Sharpe ratio

Return per unit of total volatility

0.19

-0.38

+0.57

Sortino ratio

Return per unit of downside risk

0.67

-0.22

+0.89

Omega ratio

Gain probability vs. loss probability

1.08

0.98

+0.11

Calmar ratio

Return relative to maximum drawdown

0.29

-0.70

+1.00

Martin ratio

Return relative to average drawdown

0.66

-1.17

+1.83

AHCO vs. XBIT - Sharpe Ratio Comparison

The current AHCO Sharpe Ratio is 0.19, which is higher than the XBIT Sharpe Ratio of -0.38. The chart below compares the historical Sharpe Ratios of AHCO and XBIT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


AHCOXBITDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.19

-0.38

+0.57

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.35

-0.48

+0.14

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.15

Sharpe Ratio (All Time)

Calculated using the full available price history

0.05

-0.23

+0.28

Correlation

The correlation between AHCO and XBIT is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

AHCO vs. XBIT - Dividend Comparison

Neither AHCO nor XBIT has paid dividends to shareholders.


TTM20252024202320222021
AHCO
AdaptHealth Corp.
0.00%0.00%0.00%0.00%0.00%0.00%
XBIT
XBiotech Inc.
0.00%0.00%0.00%0.00%0.00%22.46%

Drawdowns

AHCO vs. XBIT - Drawdown Comparison

The maximum AHCO drawdown since its inception was -83.84%, smaller than the maximum XBIT drawdown of -92.67%. Use the drawdown chart below to compare losses from any high point for AHCO and XBIT.


Loading graphics...

Drawdown Indicators


AHCOXBITDifference

Max Drawdown

Largest peak-to-trough decline

-83.84%

-92.67%

+8.83%

Max Drawdown (1Y)

Largest decline over 1 year

-32.19%

-39.43%

+7.24%

Max Drawdown (5Y)

Largest decline over 5 years

-83.14%

-87.21%

+4.07%

Max Drawdown (10Y)

Largest decline over 10 years

-90.72%

Current Drawdown

Current decline from peak

-70.46%

-91.38%

+20.92%

Average Drawdown

Average peak-to-trough decline

-42.62%

-69.78%

+27.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.18%

23.84%

-9.66%

Volatility

AHCO vs. XBIT - Volatility Comparison

AdaptHealth Corp. (AHCO) has a higher volatility of 15.67% compared to XBiotech Inc. (XBIT) at 7.77%. This indicates that AHCO's price experiences larger fluctuations and is considered to be riskier than XBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


AHCOXBITDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.67%

7.77%

+7.90%

Volatility (6M)

Calculated over the trailing 6-month period

36.35%

40.36%

-4.01%

Volatility (1Y)

Calculated over the trailing 1-year period

49.89%

59.87%

-9.98%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.14%

64.08%

-4.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.10%

75.92%

-20.82%

Financials

AHCO vs. XBIT - Financials Comparison

This section allows you to compare key financial metrics between AdaptHealth Corp. and XBiotech Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
846.29M
0
(AHCO) Total Revenue
(XBIT) Total Revenue
Values in USD except per share items